Search

everythinglearnresearchcommunity

for

Search:↓

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

PRP therapy may improve skin and hair conditions, but more research with standard methods is needed.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Better-designed, long-term studies are needed to optimize treatment for trichotillomania and trichophagia.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Both Platelet-Rich Plasma and Minoxidil foam increase hair count in women with hair loss, but Minoxidil is more effective. However, women were more satisfied with Platelet-Rich Plasma treatment.

Platelet-rich plasma (PRP) treatment has been found effective in promoting hair growth for alopecia patients, with minimal side effects like temporary pain and redness.

Using micro-needling, low-level laser therapy, and platelet-rich plasma together significantly improves hair growth in people with hair loss.

FGF-2&D/P nanoparticles can help treat hair loss.

Trichoscopy helps diagnose frontal fibrosing alopecia, even with unusual patterns.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

The new visual scale is a quick and effective way to measure hair loss in women.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.

Melanoma development can be linked to the breakdown of skin's melanin-producing units.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Trichoscopy helps quickly identify autoimmune diseases on the scalp but should be used with other standard tests.

Hominis Placenta helps hair grow back by increasing cell growth and a specific growth factor.

Non-obese women with hair loss have higher heart disease risk.

Platelet-Rich Plasma and stem cell therapy can increase hair count and density, but the best method for preparation and treatment still needs to be determined.

The silk fibroin hydrogel with FGF-2-liposome can potentially treat hair loss in mice.

Brandt's hedgehog has thick skin on its back and many glands near its nostrils.

Scalp areas that look normal in people with hair loss may still show signs of disease under a microscope.